Concepedia

Publication | Open Access

A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma

DOIFull Paper Access

115

Citations

23

References

2007

Year

John P. Leonard, Jonathan W. Friedberg, Anas Younes, David C. Fisher, Leo I. Gordon, Joseph O. Moore, M. S. Czuczman, Thomas P. Miller, Patrick J. Stiff, Bruce D. Cheson,
Annals of Oncology

References

YearCitations

Page 1